NCT01612325View on ClinicalTrials.gov

Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Liver Neoplasms
Interventions
DEVICE

Holmium-166 polylactic microspheres

Radioembolisation with 600 mg of Holmium-166 microspheres with a patient liver size adjusted activity. The desired whole liver dose is 60 Gy.

Trial Locations (1)

3584CX

Department of Radiology University Medical Center Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT01612325 - Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases | Biotech Hunter | Biotech Hunter